News

BioVex said that the Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in

Scientists at Kyto have isolated and cloned the Transcobalamin Receptor which has been shown to be over expressed in various forms of cancer. The primary therapeutic approach developed

The milestone was triggered by Genentech’s submission of an investigational new drug (IND) application with the FDA for an ADC utilising Seattle Genetics’ technology for the treatment of

As per the terms of the agreement, Allergan is expected to grant to Bristol-Myers Squibb exclusive worldwide rights to develop, manufacture and commercialise AGN-209323 and backup compounds. The

Zap-Hybridoma was created to improve monoclonal antibody productivity and deliver easier purification of the target product. Zap-Hybridoma was developed by InVitria’s cell culture development team. Steve Pettit, director

Lanxess will invest about EUR50m in total at the 13 hectare Jhagadia site, which will include a rubber chemicals plant and a new ion exchange resins plant. This

Both the parties said that the new programme on Lu AA21004 will consist of four clinical Phase III studies including approximately 2,000 patients with moderate to severe depression

NCX 116 has completed two phase 2 studies in patients with glaucoma and ocular hypertension that demonstrated promising results. As per the terms of the agreement, Bausch +

FDA said that the products are manufactured by Puerto Rico Beverage of Maunabo and distributed by Lord Pharmaceuticals, Bee International Distributors and Morales Distributors. The hand sanitizers are